Clinical trial
Phase 1 Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
NCT01977131 is registered in ClinicalTrials.gov with Wei Yu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
- Lead sponsor
- Wei Yu
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- September 30, 2013
- Enrollment
- 10 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.